Edesa Biotech (EDSA) Net Margin (2013 - 2020)
Edesa Biotech (EDSA) reported Net Margin of -402899.60% for fiscal Q4 2020 (quarter ended Sep 30, 2020), down 401294.14 percentage points from the prior quarter.
Powered by 
Analysis
Edesa Biotech (EDSA) Net Margin (2013 - 2020) Analysis & Trends
For FY2020 (ended Sep 30, 2020), Edesa Biotech posted Net Margin of -1935.59%, down 1259.77 percentage points from FY2019.
- Net Margin has a five-year change of -1560.86 percentage points (FY2015 to FY2020).
- By fiscal year, Net Margin came in at -675.82% in FY2019 (+1702.74 pp), -2378.56% in FY2018 (-174.91 pp), -2203.65% in FY2017 (-1808.42 pp) and -395.23% in FY2016 (-20.50 pp).
- The fiscal Q4 2020 figure ranks as the lowest quarterly Net Margin in data going back to fiscal Q1 2014.
- The high point for year-over-year Net Margin in five years was fiscal Q4 2018 (a gain of 40312.84 percentage points); the low point was fiscal Q4 2017 (a drop of 41907.92 percentage points).
- Per Business Quant data, the three fiscal quarters before Q4 2020 came in at -1605.46% (Q3 2020), -1347.89% (Q2 2020) and -1015.15% (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Edesa Biotech | 35.16 Mn | 35.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -402,899.60% |
| Jun 30, 2020 | -1,605.46% |
| Mar 31, 2020 | -1,347.89% |
| Dec 31, 2019 | -1,015.15% |
| Jun 30, 2019 | -258,801.40% |
| Sep 30, 2018 | -2,080.84% |
| Mar 31, 2018 | -2,111.61% |
| Dec 31, 2017 | -6,837.24% |
| Sep 30, 2017 | -42,393.68% |
| Jun 30, 2017 | -5,943.70% |
| Mar 31, 2017 | -1,751.34% |
| Dec 31, 2016 | -1,047.31% |
| Sep 30, 2016 | -485.76% |
| Jun 30, 2016 | -659.38% |
| Mar 31, 2016 | -263.84% |
| Dec 31, 2015 | -333.87% |
| Sep 30, 2015 | -766.19% |
| Jun 30, 2015 | 294.13% |
| Mar 31, 2015 | -227.13% |
| Dec 31, 2014 | -631.75% |
API Access
Edesa Biotech Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();